yea, the initial pilot study consisted of only 7 patients in Turkey...so there's that, lol. The results were quite compelling though:
- Intraocular inflammation began to resolve in all 7 patients on Day 1, with a median time to first response of 4 days (range 1 to 14 days)
- Complete resolution of retinal findings was achieved in 4 to 21 days (median 14 days)
- Five out of 7 patients were in remission when they reached the Day 28 visit.
They have a strong balance sheet which should get them through all three Ph3 read-outs. The erosive osteoarthritis PoC data may offer an upside surprise in July/Aug time-frame plus any progress on the ultra-orphan indications could move the dial without having to risk the Eyeguard A binary.
Market Data 
Markets 
AI
